Have antisense oligonucleotides hit their stride?
After 40 years, the drug class looks poised to finally fulfill the promise of rapid development and enter a new era of personalized medicine
After 40 years, the drug class looks poised to finally fulfill the promise of rapid development and enter a new era of personalized medicine